Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo
- PMID: 15492235
- DOI: 10.1158/0008-5472.CAN-04-1795
Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo
Abstract
Neuroblastoma is the single most common and deadly tumor of childhood and is often associated with therapy resistance. Cyclooxygenases (COXs) catalyze the conversion of arachidonic acid to prostaglandins. COX-2 is up-regulated in several adult epithelial cancers and is linked to proliferation and resistance to apoptosis. We detected COX-2 expression in neuroblastoma primary tumors and cell lines but not in normal adrenal medullas from children. Treatment of neuroblastoma cells with nonsteroidal anti-inflammatory drugs, inhibitors of COX, induced caspase-dependent apoptosis via the intrinsic mitochondrial pathway. Treatment of established neuroblastoma xenografts in nude rats with the dual COX-1/COX-2 inhibitor diclofenac or the COX-2-specific inhibitor celecoxib significantly inhibited tumor growth in vivo (P < 0.001). In vitro, arachidonic acid and diclofenac synergistically induced neuroblastoma cell death. This effect was further pronounced when lipooxygenases were simultaneously inhibited. Proton magnetic resonance spectroscopy ((1)H MRS) of neuroblastoma cells treated with COX inhibitors demonstrated accumulation of polyunsaturated fatty acids and depletion of choline compounds. Thus, (1)H MRS, which can be performed with clinical magnetic resonance scanners, is likely to provide pharmacodynamic markers of neuroblastoma response to COX inhibition. Taken together, these data suggest the use of nonsteroidal anti-inflammatory drugs as a novel adjuvant therapy for children with neuroblastoma.
Similar articles
-
NSAIDs in neuroblastoma therapy.Cancer Lett. 2005 Oct 18;228(1-2):195-201. doi: 10.1016/j.canlet.2005.01.058. Cancer Lett. 2005. PMID: 15975708 Review.
-
Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.Cancer Res. 2002 Nov 15;62(22):6706-11. Cancer Res. 2002. PMID: 12438270
-
Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.Cancer Res. 2002 Nov 1;62(21):6323-8. Cancer Res. 2002. PMID: 12414664
-
Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.Cancer Res. 2002 Feb 1;62(3):625-31. Cancer Res. 2002. PMID: 11830509
-
Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basis.Am J Clin Oncol. 2003 Aug;26(4):S66-9. doi: 10.1097/01.COC.0000074160.49879.51. Am J Clin Oncol. 2003. PMID: 12902859 Review.
Cited by
-
Is human cytomegalovirus a target in cancer therapy?Oncotarget. 2011 Dec;2(12):1329-38. doi: 10.18632/oncotarget.383. Oncotarget. 2011. PMID: 22246171 Free PMC article. Review.
-
Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases.Cancers (Basel). 2022 Sep 9;14(18):4385. doi: 10.3390/cancers14184385. Cancers (Basel). 2022. PMID: 36139546 Free PMC article. Review.
-
Neuroblastoma-related inflammation: May small doses of aspirin be suitable for small cancer patients?Oncoimmunology. 2013 Jul 1;2(7):e24658. doi: 10.4161/onci.24658. Epub 2013 Apr 30. Oncoimmunology. 2013. PMID: 24073359 Free PMC article.
-
Prostaglandin E2 promotes MYCN non-amplified neuroblastoma cell survival via β-catenin stabilization.J Cell Mol Med. 2015 Jan;19(1):210-26. doi: 10.1111/jcmm.12418. Epub 2014 Sep 30. J Cell Mol Med. 2015. PMID: 25266063 Free PMC article.
-
Inhibition of Microsomal Prostaglandin E Synthase-1 in Cancer-Associated Fibroblasts Suppresses Neuroblastoma Tumor Growth.EBioMedicine. 2018 Jun;32:84-92. doi: 10.1016/j.ebiom.2018.05.008. Epub 2018 May 24. EBioMedicine. 2018. PMID: 29804818 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous